Willis Towers Watson’s Q4 InsurTech briefing showed another record-breaking quarter for deals but one crucial aspect was the continued trend of later-stage funding growth coupled with early-stage retraction.
Willis Towers Watson’s Q4 InsurTech briefing showed another record-breaking quarter for deals but one crucial aspect was the continued trend of later-stage funding growth coupled with early-stage retraction.